N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
McCallum, Matthew, De Marco, Anna, Lempp, Florian A., Tortorici, M. Alejandra, Pinto, Dora, Walls, Alexandra C., Beltramello, Martina, Chen, Alex +26 more·2021·Cell
Cited by (909)
Items 601–700 of 909
- Design and Immunoinformatic Assessment of Candidate Multivariant mRNA Vaccine Construct against Immune Escape Variants of SARS-CoV-2Mushtaq Hussain, Anusha Amanullah, Ayesha Aslam, Fozia Raza, Shabana Arzoo, Iffat Waqar Qureshi, Humera Waheed, Nusrat Jabeen, Sanya Shabbir, Muneeba Ahsan Sayeed et al. · 2022 · Polymers
- Involvement of sialoglycans in SARS‐COV ‐2 infection: Opportunities and challenges for glyco‐based inhibitorsSakonwan Kuhaudomlarp, Anne Imberty · 2022 · IUBMB Life
- Exploring Factors Influencing Changes in Incidence and Severity of Multisystem Inflammatory Syndrome in ChildrenPasquale Castaldo, Gabriele d’Alanno, Giovanni Battista Biserni, Mattia Moratti, Francesca Conti, Marianna Fabi, Marcello Lanari · 2023 · Pathogens
- Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2Paula Ruiz-Rodríguez, Clara Francés-Gómez, Álvaro Chiner‐Oms, Mariana G. López, Santiago Jiménez-Serrano, Irving Cancino‐Muñoz, Paula Ruiz-Hueso, Manuela Torres‐Puente, Maria Alma Bracho, Giuseppe D’Auria et al. · 2021 · mBio
- SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccinationPrerna Arora, Amy Madeleine Kempf, Inga Nehlmeier, Luise Graichen, Martin Sebastian Winkler, Martin Lier, Sebastian R. Schulz, Hans‐Martin Jäck, Anne Cossmann, Metodi V. Stankov et al. · 2022 · Cell Reports
- The Emergence of SARS-CoV-2 Variants With a Lower Antibody Response: A Genomic and Clinical PerspectiveSuvro Biswas, Shafi Mahmud, Mohasana Akter Mita, Shamima Afrose, Md. Robiul Hasan, Gobindo Kumar Paul, Mst. Sharmin Sultana Shimu, Md. Salah Uddin, Shahriar Zaman, Moon Nyeo Park et al. · 2022 · Frontiers in Medicine
- Immune-based therapeutic approaches in COVID-19Aysan Moeinafshar, Niloufar Yazdanpanah, Nima Rezaei · 2022 · Biomedicine & Pharmacotherapy
- SARS-CoV-2 Delta variant isolates from vaccinated individualsLauren M. Brinkac, Sheila Diepold, Shane Mitchell, Stephanie Sarnese, Lee F. Kolakowski, William M. Nelson, Katharine Jennings · 2022 · BMC Genomics
- Analysis of SARS-CoV-2 Mutations Over Time Reveals Increasing Prevalence of Variants in the Spike Protein and RNA-Dependent RNA PolymeraseWilliam M. Showers, Sonia M. Leach, K. Kechris, M. Strong · 2021 · bioRxiv
- A trimeric NTD and RBD SARS-CoV-2 subunit vaccine induced protective immunity in CAG-hACE2 transgenic mice and rhesus macaquesJiaping Yu, Wenrong Yao, Yingsong Hu, Shuang Wu, Jiao Li, Hongjun Zhou, Kunxue Hong, Jianping Chen, Longding Liu, Ke Lan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
- Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responsesAlexandra C. Walls, Kaitlin R. Sprouse, Anshu Joshi, John E. Bowen, Nicholas Franko, Mary Jane Navarro, Cameron Stewart, Matthew McCallum, Erin A. Goecker, Emily Degli-Angeli et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
- Reverse mutational scanning of spike BA.2.86 identifies epitopes contributing to immune escape from polyclonal seraNajat Bdeir, Tatjana Lüddecke, Henrike Maaß, Stefan Schmelz, Ulfert Rand, Henning Jacobsen, Kristin Metzdorf, Upasana Kulkarni, Anne Cossmann, Metodi V. Stankov et al. · 2024 · medRxiv
- Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harbouring both NTD and RBD potent antibodiesWenling Jiang, Yanan Jiang, Hui Sun, Tingting Deng, Kunyu Yu, Qianjiao Fang, Huimin Ge, Miaoling Lan, Yanling Lin, Zhongyue Fang et al. · 2024 · Emerging Microbes & Infections
- RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaquesHélène Letscher, Delphine Guilligay, Grégory Effantin, Axelle Amen, Guidenn Sulbarán, Judith A. Burger, Laëtitia Bossevot, Laura Junges, Marco Léonec, Julie Morin et al. · 2025 · npj Vaccines
- A rare B cell clonotype imprinted by ancestral SARS-CoV-2 develops cross-sarbecovirus neutralization in immune recallsXixian Chen, Ling Li, Ruiping Du, Zuowei Wang, Yunjian Li, Yi Sun, Rongrong Qin, Hualong Feng, Lin Hu, Xuanyi Chen et al. · 2025 · Cell Reports
- Functional and structural basis of Omicron BA.3.2.1 spikeYan Wang, Yanping Hu, Zhenhang Chen, Jing Zou, Ke Zhang, Ping Ren, Pei‐Yong Shi, Bo Liang, Xuping Xie · 2026 · Cell Reports
- Mutational escape prevention by combination of four neutralizing antibodies that target RBD conserved regions and stem helixHaoneng Tang, Yong Ke, Yunji Liao, Yanlin Bian, Yunsheng Yuan, Ziqi Wang, Yang Li, Hang Ma, Tao Sun, Baohong Zhang et al. · 2022 · Virologica Sinica
- Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variantsWenjuan Du, Rick Janssens, Anna Z. Mykytyn, Wentao Li, Dubravka Drabek, Rien van Haperen, Marianthi Chatziandreou, Melanie Rissmann, Joline van der Lee, Melissa van Dortmondt et al. · 2023 · Frontiers in Immunology
- Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individualsEugenia Galeota, Valeria Bevilacqua, Andrea Gobbini, Paola Gruarin, Mauro Bombaci, Elisa Pesce, Andrea Favalli, Andrea Lombardi, Francesca Vincenti, Jessica Ongaro et al. · 2024 · Clinical Immunology
- Intra-Host SARS-CoV-2 Evolution in the Gut of Mucosally-Infected Chlorocebus aethiops (African Green Monkeys)Lori A. Rowe, Brandon J. Beddingfield, Kelly A. Goff, Stephanie Z. Killeen, Nicole R. Chirichella, Alexandra Melton, Chad J. Roy, Nicholas J. Maness · 2022 · Viruses
- Phylogenetic analysis and comparative genomics of SARS-CoV-2 from survivor and non-survivor COVID-19 patients in Cordoba, ArgentinaNadia B. Olivero, Ana Silvia Gonzalez-Reiche, Viviana Elizabeth Re, Gonzalo Castro, María Belén Pisano, Paola E. Sicilia, María Gabriela Barbás, Zenab Khan, Adriana van de Guchte, Jayeeta Dutta et al. · 2022 · BMC Genomics
- Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overviewNastaran Hadizadeh, Mousa Naderi, Jafar Khezri, Meysam Yazdani, Mehdi Shamsara, Ehsan Hashemi · 2022 · Journal of Diabetes & Metabolic Disorders
- Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New JerseyBarun Mathema, Liang Chen, Pengfei Wang, Marcus H. Cunningham, José R. Mediavilla, Kar Fai Chow, Yang Luo, Yanan Zhao, Kaelea Composto, Jerry M. Zuckerman et al. · 2022 · mBio
- Evaluating the effect of SARS-CoV-2 spike mutations with a linear doubly robust learnerXin Wang, Mingda Hu, Bo Liu, Huifang Xu, Yuan Jin, Boqian Wang, Yunxiang Zhao, Jun Wu, Junjie Yue, Hongguang Ren · 2023 · Frontiers in Cellular and Infection Microbiology
- Highly sensitive wastewater surveillance of SARS-CoV-2 variants by targeted next-generation amplicon sequencing provides early warning of incursion in Victoria, AustraliaJames E. Merrett, Monica Nolan, Leon M. Hartman, Nijoy John, Brianna Flynn, Louise Baker, Christelle Schang, David McCarthy, David Lister, Ngai Ning Cheng et al. · 2024 · Applied and Environmental Microbiology
- Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV ‐2Bharat Madan, Eswar R. Reddem, Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Yaoxing Huang, Ahmed S. Fahad, Matheus Oliveira de Souza, Bailey B. Banach, Sheila N. López Acevedo et al. · 2021 · AIChE Journal
- Molecular Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Isolates From Central Inner SardiniaPaolo Malune, Giovanna Piras, Maria Itria Monne, Maura Fiamma, Rosanna Asproni, Tatiana Fancello, Antonio Luigi Manai, Franco Carta, Giovanna Pira, Patrizia Fancello et al. · 2022 · Frontiers in Microbiology
- Whole-Genome Sequencing of SARS-CoV-2 Infection in a Cluster of Immunocompromised Children in IndonesiaNina Dwi Putri, Edison Johar, Yora Permata Dewi, Nuri Dyah Indrasari, Dewi Wulandari, Merci Monica Pasaribu, Teny Tjitra Sari, Fitri Prima Cakti, Madeline Ramdhani Jasin, Tartila Tartila et al. · 2022 · Frontiers in Medicine
- A Short Series of Case Reports of COVID-19 in Immunocompromised PatientsMitali Mishra, Aleena Zahra, Lokendra V. Chauhan, Riddhi Thakkar, James Ng, Shreyas Joshi, Eric D. Spitzer, Luis A. Marcos, Walter Ian Lipkin, Nischay Mishra · 2022 · Viruses
- Analysis of co-occurring and mutually exclusive amino acid changes and detection of convergent and divergent evolution events in SARS-CoV-2Ruba Al Khalaf, Anna Bernasconi, Pietro Pinoli, Stefano Ceri · 2022 · Computational and Structural Biotechnology Journal
- Evolution of the SARS-CoV-2 pandemic in IndiaVarsha Atul Potdar, Sarah Cherian · 2022 · Medical Journal Armed Forces India
- High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spikeTimothy J.C. Tan, Zongjun Mou, Ruipeng Lei, Wenhao O. Ouyang, Meng Yuan, Ge Song, Raiees Andrabi, Ian A. Wilson, Collin Kieffer, Xinghong Dai et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
- Spike Protein–Fibrinogen Interaction: A Novel Immune Evasion Strategy of SARS-CoV-2?Saroj Kumar Panda, Shashi Bala Singh, Parth Sarthi Sen Gupta · 2025 · ACS Pharmacology & Translational Science
- Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccinesSandhya Bangaru, Abigail M. Jackson, Jeffrey Copps, Monica L. Fernández‐Quintero, Jonathan L. Torres, Sara T. Richey, Bartek Nogal, Leigh M. Sewall, Alba Torrents de la Peña, Asma Rehman et al. · 2025 · Cell Reports
- Heterogeneous Evolution Among SARS‐CoV‐2 Genes and Variants of ConcernLuis Daniel González-Vázquez, Paula Iglesias-Rivas, David Ferreiro, Miguel Arenas · 2025 · Journal of Medical Virology
- Repeated COVID-19 vaccine boosters elicit variant-specific memory B cells in humansM. Alejandra Tortorici, Kaitlin R. Sprouse, Amin Addetia, Jack T Brown, Jimin Lee, Cameron Stewart, Benjamin Merz, Alex Harteloo, Anna Elias-Warren, Helen Y. Chu et al. · 2026 · Cell Reports
- Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapiesShuchen Feng, Gail Reid, Nina M. Clark, Amanda Harrington, Susan L. Uprichard, Susan C. Baker · 2024 · Virology Journal
- Advancements in the Development of Anti-SARS-CoV-2 TherapeuticsJunjie Huang, Qianqian Ma, Zhengding Su, Xiyao Cheng · 2024 · International Journal of Molecular Sciences
- Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoVNaveenchandra Suryadevara, Nurgun Kose, Sandhya Bangaru, Elad Binshtein, Jennifer E. Munt, David R. Martinez, Alexandra Schäfer, Luke Myers, Trevor Scobey, Robert H. Carnahan et al. · 2024 · Journal of Clinical Investigation
- Gene expression analysis of MCF7 cell lines of breast cancer treated with herbal extract of Cissampelos pareira revealed association with viral diseasesEmine Güven · 2021 · Gene Reports
- Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cellsGladys J. Keitany, Benjamin E. Rubin, Meghan E. Garrett, Andrea Musa, Jeff Tracy, Yu Liang, Peter Ebert, Amanda J. Moore, Jonathan Guan, Erica L. Eggers et al. · 2023 · Cell chemical biology
- Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control SubjectsRichard Vollenberg, Eva Ulla Lorentzen, Joachim Kühn, Tobias Max Nowacki, Jörn Arne Meier, Jonel Trebicka, Phil‐Robin Tepasse · 2023 · Vaccines
- Neutralization of Different Variants of SARS-CoV-2 by a F(ab′)2 Preparation from Sera of Horses Immunized with the Viral Receptor Binding DomainMariajosé Rodríguez, Mariana del Valle Cepeda, Carlos Bello, Miguel Angel Lopez, Yoneira Fabiola Sulbarán, Carmen Luisa Loureiro, Ferdinando Liprandi, Rossana Celeste Jaspe, Hector Rafael Rangel, Flor Helene Pujol · 2023 · Antibodies
- Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination CohortMichael Schöfbänker, Rieke Neddermeyer, Theresa Günther, MM Mueller, Marie-Luise Romberg, Nica Classen, Marc Tim Hennies, Eike Roman Hrincius, Stephan Ludwig, Joachim Kühn et al. · 2023 · Vaccines
- Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virusKetaren, Natalia E, Mast, Fred D, Fridy, Peter C, Olivier, Jean Paul, Sanyal, Tanmoy, Sali, Andrej, Chait, Brian T, Rout, Michael P, Aitchison, John D · 2024 · eLife
- Enhanced antibody response to the conformational non-RBD region via DNA prime-protein boost elicits broad cross-neutralization against SARS-CoV-2 variantsYun-Fei Ma, Kun Chen, Bowen Xie, Jiayi Zhu, Xuan He, Chunying Chen, Yuhe Renee Yang, Ye Liu · 2024 · Emerging Microbes & Infections
- Persistence of SARS-CoV-2 Alpha Variant in White-Tailed Deer, Ohio, USANatalie N. Tarbuck, Sofya K. Garushyants, Dillon S. McBride, Patricia M. Dennis, John Franks, Karlie Woodard, Austin Shamblin, Michael G. Sovic, Derek T. Collins, Kyle Van Why et al. · 2025 · Emerging infectious diseases
- Mutational profile confers increased stability of SARS-CoV-2 spike protein in Brazilian isolatesFelipe Rocha da Silva Santos, Marcela Santiago Pacheco de Azevedo, Mônica Bielavsky, Hernan Hermes Monteiro da Costa, Daniela Gomes Ribeiro, Gleidson Guedes do Nascimento, Gabrielle Menezes Paz Marcondes, Beatriz Portugal de Castro, Daniel Ferreira de Lima Neto, Carlos Roberto Prudêncio · 2021 · Journal of Biomolecular Structure and Dynamics
- Predicting spike protein NTD mutations of SARS-CoV-2 causing immune evasion by molecular dynamics simulationsLiping Zhou, Leyun Wu, Cheng Peng, Yanqing Yang, Yulong Shi, Likun Gong, Zhijian Xu, Weiliang Zhu · 2022 · Physical Chemistry Chemical Physics
- Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant VirusesYinon Levy, Ron Alcalay, Anat Zvi, Efi Makdasi, Eldar Peretz, Tal Noy-Porat, Theodor Chitlaru, Michal Mandelboim, Ohad Mazor, Ronit Rosenfeld · 2022 · Vaccines
- Host–pathogen dynamics in longitudinal clinical specimens from patients with COVID-19Michelle J. Lin, Victoria M. Rachleff, Hong Jian Xie, Lasata Shrestha, Nicole A. P. Lieberman, Vikas Peddu, Amin Addetia, Amanda M. Casto, Nathan Breit, Patrick C. Mathias et al. · 2022 · Scientific Reports
- Detecting Potentially Adaptive Mutations from the Parallel and Fixed Patterns in SARS-CoV-2 EvolutionChengyang Ji, Na Han, Ye‐Xiao Cheng, Jingzhe Shang, Shenghui Weng, Rong Yang, Hangyu Zhou, Aiping Wu · 2022 · Viruses
- Mutational induction in SARS-CoV-2 major lineages by experimental exposure to neutralising seraMartina Brandolini, Giorgio Dirani, Francesca Taddei, Silvia Zannoli, Agnese Denicolò, Valentina Arfilli, Arianna Battisti, Martina Manera, Andrea Mancini, Laura Grumiro et al. · 2022 · Scientific Reports
- Tracking mutational semantics of SARS-CoV-2 genomesRohan P. Singh, Sunil Nagpal, Nishal Kumar Pinna, Sharmila S. Mande · 2022 · Scientific Reports
- Coronavirus Entry InhibitorsQiaoshuai Lan, Shuai Xia, Lu Lu · 2022 · Advances in experimental medicine and biology
- Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individualsAurélien Sokal, Giovanna Barba Spaeth, Ignacio Fernández, Matteo Broketa, Imane Azzaoui, Andrea de La Selle, Alexis Vandenberghe, Slim Fourati, Anaïs Roeser, Annalisa Meola et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
- B.1.617.3 SARS CoV-2 spike E156G/Δ157-158 mutations contribute to reduced neutralization sensitivity and increased infectivityTarun Kumar Mishra, Garima Joshi, Atul Kumar, Rishikesh Dalavi, Pankaj Pandey, Sanjeev Shukla, Ram Kumar Mishra, Ajit G. Chande · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
- Structural basis for antibody resistance to SARS-CoV-2 omicron variantGabriele Cerutti, Yicheng Guo, Lihong Liu, Zhening Zhang, Liyuan Liu, Yang Luo, Yiming Huang, Harris H. Wang, David D. Ho, Zizhang Sheng et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
- Identification and genomic characterisation of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern AfricaGraeme Dor, Dikeledi Kekana, Ryan Hisner, Darren Patrick Martin, Bette Korber, Timo Ernst, Avram Levy, David John Speers, Stuart Grant Turville, Vitali Sintchenko et al. · 2025 · medRxiv
- Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responsesRafael Bayarri‐Olmos, Adrian Sutta, Anne Rosbjerg, Mie Mandal Mortensen, Charlotte Helgstrand, Per Franklin Nielsen, Laura Pérez‐Alós, Beatriz González‐García, Laust Bruun Johnsen, Finn Matthiesen et al. · 2024 · Frontiers in Immunology
- Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infectionsGrace Quirk, Marta V. Schoenle, Kameron L. Peyton, Jennifer L. Uhrlaub, Branden Lau, Chieh-Yu Liang, Jefferey L. Burgess, Katherine Ellingson, Shawn C. Beitel, James K. Romine et al. · 2025 · Nature Immunology
- Discovery of Synergistic Broadly Neutralizing Antibodies Targeting Non-Dominant Epitopes on SARS-CoV-2 RBD and NTDHualong Feng, Zuowei Wang, Ling Li, Yunjian Li, Maosheng Lu, Xixian Chen, Lin Hu, Yi Sun, Ruiping Du, Rongrong Qin et al. · 2025 · Vaccines
- Structural Analysis of the SARS ‐ CoV ‐2 Spike N‐Terminal Domain Across Wild‐Type and Recent Variants: A Comparative StudyMiriana Quaranta, Allegra Via, Stefano Pascarella · 2025 · Proteins Structure Function and Bioinformatics
- An Electrostatically-steered Conformational Selection Mechanism Promotes SARS-CoV-2 Spike Protein VariationMarija Sorokina, Jaydeep Belapure, Christian Tüting, Reinhard Paschke, Ioannis Papasotiriou, João Rodrigues, Panagiotis L. Kastritis · 2022 · Journal of Molecular Biology
- Multiplex RT Real-Time PCR Based on Target Failure to Detect and Identify Different Variants of SARS-CoV-2: A Feasible Method That Can Be Applied in Clinical LaboratoriesVan Hung Pham, Huong Thien Pham, Mario Giosuè Balzanelli, Pietro Distratis, Rita Lazzaro, Quốc Việt Nguyễn, Viet Quoc Tran, Duy Khanh Tran, Luan Duy Phan, Sang Minh Pham et al. · 2023 · Diagnostics
- The Lambda Variant in Argentina: Analyzing the Evolution and Spread of SARS-CoV-2 Lineage C.37Mercedes Soledad Nabaes Jodar, Carolina Torres, Laura Noelia Mojsiejczuk, Dolores Acuña, Laura Elena Valinotto, Stephanie Goya, Mónica Inés Natale, Silvina Beatriz Lusso, Sofía Alexay, Ariel Amadío et al. · 2023 · Viruses
- Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review)Tong Zhang, Di Yang, Liang Tang, Yu Hu · 2024 · Molecular Medicine Reports
- Unraveling the structural and functional dimensions of SARS-CoV2 proteins in the context of COVID-19 pathogenesis and therapeuticsAniruddh Jhanwar, Dipika Sharma, Uddipan Das · 2024 · International Journal of Biological Macromolecules
- Case reports of persistent SARS-CoV-2 infection outline within-host viral evolution in immunocompromised patientsLuca Ruotolo, Silvia Silenzi, Beatrice Mola, Margherita Ortalli, Tiziana Lazzarotto, Giada Rossini · 2024 · Virology Journal
- Determination of resilience of a panel of broadly neutralizing mAbs to emerging variants of SARS-CoV-2 generated using reverse geneticsMadeeha Afzal, Diana Melnyk, Thomas Courty, Lisa M. Schimanski, Michelle L. Hill, Stuart J. D. Neil, Tiong Kit Tan, William James · 2025 · iScience
- Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variantsAJ Venkatakrishnan, Praveen Anand, Patrick J. Lenehan, Pritha Ghosh, Rohit Suratekar, Eli Silvert, Colin Pawlowski, Abhishek Siroha, Dibyendu Roy Chowdhury, John Charles O’Horo et al. · 2023 · Scientific Reports
- SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strainJianhua Li, Xiaoyan Li, Haiyan Mao, Chen Huang, Yi Sun, Liangbin Miao, Jiaxuan Li, Wanchen Song, Yanjun Zhang, Jinsong Huang et al. · 2023 · Virus Research
- Subunit vaccine raised against the SARS‐CoV‐2 spike of Delta and Omicron variantsFeng Sheng, Zechang Fan, Keyue Zhou, Shanshan Ma, Mingzheng Liang, He Zhang, Yubiao Xie, Zhuo Ha, Ningyi Jin, Huijun Lu · 2023 · Journal of Medical Virology
- Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variantsKan Li, Richard H. C. Huntwork, G. Horn, Milite Abraha, K. Hastie, Hao-Yang Li, Vamseedhar Rayaprolu, Eduardo Olmedillas, E. Feeney, Ken Cronin et al. · 2023 · Journal of Virology
- Development of automated microfluidic immunoassays for the detection of SARS-CoV-2 antibodies and antigenLinwood Johnson, Maggie L. Bartlett, Francisco Ramirez, Christopher D. Heger, Darci R. Smith · 2023 · Journal of Immunological Methods
- Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron WavesHan Di, Elizabeth A. Pusch, Joyce E. Jones, Nicholas A. Kovacs, Norman Hassell, Mili Sheth, Kelly Sabrina Lynn, Matthew W. Keller, Malania M. Wilson, Lisa Mari Keong et al. · 2024 · Vaccines
- Neutralizing monoclonal antibodies against highly pathogenic coronavirusesRong Xiang, Yang Wang, Lili Wang, Xiaoqian Deng, Shanshan Huo, Shibo Jiang, Fei Yu · 2021 · Current Opinion in Virology
- Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodiesKatharina Müller, Philipp Girl, Andreas Giebl, Stefanie Grützner, Markus H. Antwerpen, Elham Khatamzas, Roman Wölfel, Heiner von Buttlar · 2021 · Virus Genes
- Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2Su Jin Lee, Yujin Kim, Dae‐Gyun Ahn · 2022 · Journal of Microbiology and Biotechnology
- SARS-CoV-2 variants of concern, variants of interest and lineage A.27 are on the rise in Côte d’IvoireEtilé A. Anoh, Grit Schubert, Oby Wayoro, Pacôme Monemo, Essia Belarbi, Andreas Sachse, Sébastien Calvignac‐Spencer, Fabian Hubertus Leendertz, Bamourou Diané, Chantal G. Akoua-Koffi · 2021 · medRxiv
- SARS-CoV-2-specific memory B cells can persist in the elderly despite loss of neutralising antibodiesAnna Jeffery-Smith, Alice R. Burton, Sabela Lens, Chloe Rees-Spear, Monika Patel, Robin Gopal, Luke Muir, Felicity Aiano, Katie J. Doores, J. Yimmy Chow et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
- A novel B.1.1.523 SARS-CoV-2 variant that combines many spike mutations linked to immune evasion with current variants of concernBrian M. J. W. van der Veer, Jozef Dingemans, Lieke B. van Alphen, Christian J. P. A. Hoebe, Paul H. M. Savelkoul · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
- Conformational dynamics and allosteric modulation of the SARS-CoV-2 spikeMarco Aurelio Díaz-Salinas, Qi Li, Monir Ejemel, Leonid Yurkovetskiy, Jeremy Luban, Kuang Shen, Yang Wang, James B. Munro · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
- Structural dynamics in the evolution of SARS-CoV-2 spike glycoproteinValeria Calvaresi, Antoni G. Wrobel, Joanna Toporowska, Dietmar Hammerschmid, Katie J. Doores, Richard T. Bradshaw, Ricardo B. Parsons, Donald J. Benton, Chloë Roustan, Eamonn Reading et al. · 2022 · Research Square
- Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2Filippo Bianchini, Virginia Crivelli, Morgan E. Abernathy, Concetta Guerra, Martin Palus, Jonathan Muri, Harold Marcotte, Antonio Piralla, Mattia Pedotti, Raoul De Gasparo et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
- Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatmentCaterina Elisa Faliti, Fabliha A. Anam, Narayanaiah Cheedarla, Matthew Charles Woodruff, Sabeena Y. Usman, Martin C. Runnstrom, Trinh T. P. Van, Shuya Y. Kyu, Hasan Ahmed, Andrea Morrison-Porter et al. · 2023 · medRxiv
- Recombination Events Among SARS-CoV-2 Omicron Subvariants: Impact on Spike Interaction With ACE2 Receptor and Neutralizing AntibodiesMarwa Arbi, Marwa Khedhiri, Kaouther Ayouni, Oussema Souiai, Samar Dhouib, Nidhal Ghanmi, Alia Benkahla, Henda Triki, S Boubaker · 2024 · Evolutionary Bioinformatics
- Decoding omicron: Genetic insight into its transmission dynamics, severity spectrum and ever-evolving strategies of immune escape in comparison with other SARS-CoV-2 variantsKundan Tandel, Divya Niveditha, Sanjay Pratap Singh, Kavita Bala Anand, Vaishnavi Shinde, Mayank Ghedia, Ashwini Sondakar, Mahesh Reddy · 2025 · Diagnostic Microbiology and Infectious Disease
- Differential severity of SARS-CoV-2 variant infections in children and adults with COVID-19Noah Brazer, Venice Servellita, Chengshi Jin, Abiodun Foresythe, Miriam Oseguera, Jenny Nguyen, Nanami Sumimoto, Hee Jae Huh, Andries Feder, Sanchita Bhattacharya et al. · 2025 · Journal of Clinical Virology
- Investigating the evolutionary dynamics and mutational pattern of SARS-CoV-2 spike gene on selected SARS-CoV-2 variantsBachir Balech, Alessandra Lo Presti, Claudia Telegrafo, Lucia Maisto, Emanuela Giombini, Angela Di Martino, Luigina Ambrosio, Apollonia Tullo, Paola Stefanelli · 2025 · PLoS ONE
- Detection and differentiation of murine leukemia virus (MLV) and murine stem cell virus (MSCV) and therefrom derived nucleic acidsWolfram Volkwein, Melanie Pavlovic, Martina Anton, Maren Haase, Thorsten Stellberger, Amin Jarrar, Ulrich Busch, Armin E. Baiker · 2021 · Journal of Virological Methods
- Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunityRebecca Jonczyk, Nils Stanislawski, Lisa K. Seiler, Somayeh Ahani, Arne Bueltemeier, Frank Stahl, Sascha Beutel, Holger Blume, Corinna Hauß, Anette Melk et al. · 2022 · Journal of Clinical Virology
- Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike proteinXiaofeng Li, Liudmila Kulakova, Kezzia S. Jones, E. Toth, M. Mitchell, Qiana Mendez, Michael P. Weiner, T. Fuerst · 2023 · New Biotechnology
- Identification of an IGHV3-53-Encoded RBD-Targeting Cross-Neutralizing Antibody from an Early COVID-19 ConvalescentYuanyuan Hu, Caiqin Hu, Shuo Wang, Li Ren, Yanling Hao, Zheng Wang, Ying Liu, Junwei Su, Biao Zhu, Dan Li et al. · 2024 · Pathogens
- Dynamic expedition of leading mutations in SARS-CoV-2 spike glycoproteinsHasan, Muhammad, He, Zhouyi, Jia, Mengqi, Leung, Alvin C.F., Natarajan, Kathiresan, Xu, Wentao, Yap, Shanqi, Zhou, Feng, Chen, Shihong, Su, Hailei et al. · 2024 · Computational and Structural Biotechnology Journal
- Progressive Evolutionary Dynamics of Gene-Specific ω Led to the Emergence of Novel SARS-CoV-2 Strains Having Super-Infectivity and Virulence with Vaccine NeutralizationAmit K. Maiti · 2024 · International Journal of Molecular Sciences
- Enhanced detection and molecular modeling of adaptive mutations in SARS-CoV-2 coding and non-coding regions using the c/µ testNicholas Joseph Paradis, Chun Fu Wu · 2024 · Virus Evolution
- Proteomic Approach for Comparative Analysis of the Spike Protein of SARS-CoV-2 Omicron (B.1.1.529) Variant and Other Pango LineagesMukul Jain, Nil Patil, Darshil Gor, Mohit Kumar Sharma, Neha Goel, Prashant Kaushik · 2022 · Proteomes
- Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serumYuqi Zhu, Xinyi Yang, Jingna Xun, Jun Liu, Qing Wen, Yixiao Lin, Xiaoting Shen, Jun Chen, Songhua Yuan, Xiaying Zhao et al. · 2022 · Virologica Sinica
- SARS-CoV-2 Omicron Variant Genomic and Phylogenetic Analysis in Iraqi Kurdistan RegionSevan Omer Majed, Suhad Asad Mustafa, Paywast Jamal Jalal, Mohammed Hassan Fatah, Monika Henryka Miasko, Zanko Hassan Jawhar, A. Karim · 2023 · Genes